| Product Code: ETC7638341 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Precision Oncology Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Precision Oncology Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Precision Oncology Market - Industry Life Cycle |
3.4 Ireland Precision Oncology Market - Porter's Five Forces |
3.5 Ireland Precision Oncology Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Ireland Precision Oncology Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.7 Ireland Precision Oncology Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 Ireland Precision Oncology Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Ireland |
4.2.2 Rising demand for personalized medicine and targeted therapies |
4.2.3 Technological advancements in precision oncology |
4.3 Market Restraints |
4.3.1 High cost of precision oncology treatments |
4.3.2 Limited access to precision oncology services in some regions |
4.3.3 Regulatory challenges and reimbursement issues |
5 Ireland Precision Oncology Market Trends |
6 Ireland Precision Oncology Market, By Types |
6.1 Ireland Precision Oncology Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Precision Oncology Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Ireland Precision Oncology Market Revenues & Volume, By Diagnostics, 2021- 2031F |
6.1.4 Ireland Precision Oncology Market Revenues & Volume, By Therapeutics, 2021- 2031F |
6.2 Ireland Precision Oncology Market, By Cancer Type |
6.2.1 Overview and Analysis |
6.2.2 Ireland Precision Oncology Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.2.3 Ireland Precision Oncology Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.2.4 Ireland Precision Oncology Market Revenues & Volume, By Cervical Cancer, 2021- 2031F |
6.2.5 Ireland Precision Oncology Market Revenues & Volume, By Prostate Cancer, 2021- 2031F |
6.2.6 Ireland Precision Oncology Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.2.7 Ireland Precision Oncology Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Ireland Precision Oncology Market, By End-use |
6.3.1 Overview and Analysis |
6.3.2 Ireland Precision Oncology Market Revenues & Volume, By Hospitals & Diagnostic Laboratories, 2021- 2031F |
6.3.3 Ireland Precision Oncology Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.3.4 Ireland Precision Oncology Market Revenues & Volume, By Healthcare Data Companies, 2021- 2031F |
7 Ireland Precision Oncology Market Import-Export Trade Statistics |
7.1 Ireland Precision Oncology Market Export to Major Countries |
7.2 Ireland Precision Oncology Market Imports from Major Countries |
8 Ireland Precision Oncology Market Key Performance Indicators |
8.1 Average turnaround time for precision oncology test results |
8.2 Patient satisfaction with precision oncology services |
8.3 Number of clinical trials incorporating precision oncology approaches |
8.4 Percentage of oncologists trained in precision oncology techniques |
8.5 Rate of adoption of precision oncology treatments by healthcare providers |
9 Ireland Precision Oncology Market - Opportunity Assessment |
9.1 Ireland Precision Oncology Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Ireland Precision Oncology Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.3 Ireland Precision Oncology Market Opportunity Assessment, By End-use, 2021 & 2031F |
10 Ireland Precision Oncology Market - Competitive Landscape |
10.1 Ireland Precision Oncology Market Revenue Share, By Companies, 2024 |
10.2 Ireland Precision Oncology Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here